BioLattice Opthalmics


BioLattice Ophthalmics, Inc. is dedicated to revolutionizing tissue repair, starting with cornea. They develop engineered cornea solutions as an alternative to donor tissue, aiming to restore vision and expand patient access to tissue repair solutions. The company focuses on transforming innovative ideas into medical products through partnerships, licensing, and de-risking technology via pre-clinical validation.

Industries

biotechnology

Nr. of Employees

small (1-50)

BioLattice Opthalmics

Philadelphia, Pennsylvania, United States, North America


Products

Engineered corneal implant (development-stage)

A full-thickness engineered corneal implant designed to serve as an alternative to donor cornea tissue and to provide corrective vision; currently in development and pre-clinical validation stages.


Services

Technology rescue and de-risking

Acquisition of dormant academic assets and development through pre-clinical validation to prepare IP for industry licensing.

Pre-clinical validation and translational development

Non-clinical validation activities and translational workflows to demonstrate safety and functional performance prior to commercialization or licensing.

IP licensing and partnership facilitation

Identification and engagement of potential industry licensees and contract organizations to enable market access for developed technologies.

Expertise Areas

  • Tissue engineering
  • Corneal implant development
  • Pre-clinical validation
  • Translational commercialization
  • Show More (4)

Key Technologies

  • Tissue engineering
  • Engineered tissue scaffolds
  • Corneal implant design
  • Pre-clinical validation models
  • Show More (2)

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.